Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 25;15(6):e40944.
doi: 10.7759/cureus.40944. eCollection 2023 Jun.

Sulfhemoglobinemia in a 53-Year-Old With a History of Phenazopyridine Misuse

Matthew Soderstrom  1 , Daniel V Foster  2 , Zachariah S Hamidi  1 , Jess T Anderson  2
Affiliations
Case Reports

Sulfhemoglobinemia in a 53-Year-Old With a History of Phenazopyridine Misuse

Matthew Soderstrom et al. Cureus. .

Abstract

Sulfhemoglobin is formed by the irreversible bonding of sulfur atoms to the heme molecule. Oxygen is then unable to bind the heme molecule, rendering the hemoglobin molecule unable to carry oxygen. The most common etiology of sulfhemoglobinemia is the use/misuse of sulfur-containing medications such as AZO. Unlike methemoglobin, sulfhemoglobin, due to its irreversible binding, has no antidote, and the treatment is ultimately supportive. We present a case of a 53-year-old female who presented to the emergency room endorsing dysuria and was noted to have abnormally low oxygen saturation (SpO2) despite having high arterial oxygen pressure (PaO2) on blood gas. History was significant for dysuria developed while traveling and the use of over-the-counter AZO four times daily for the past 10 days. She was diagnosed with a presumed dyshemoglobinemia and, upon return of send-out labs, was confirmed to have sulfhemoglobinemia attributed to phenazopyridine. This case highlights the importance of the recognition of potential dyshemoglobinemias and consideration of sulfhemoglobinemia as a potential causative etiology, especially in patients taking sulfur-containing medications.

Keywords: adverse reaction; dyshemoglobinemia; phenazopyridine; sulfhemoglobinemia; toxicology.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Hemoglobin Dissociation Curve
Image Credits: Matthew A. Soderstrom
See this image and copyright information in PMC

References

    1. Methemoglobinemia and sulfhemoglobinemia in two pediatric patients after ingestion of hydroxylamine sulfate. Gharahbaghian L, Massoudian B, DiMassa G. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729224/ West J Emerg Med. 2009;10:197–201. - PMC - PubMed
    1. Methemoglobinemia and sulfhemoglobinemia. Finch CA. N Engl J Med. 1948;239:470–478. - PubMed
    1. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Ash-Bernal R, Wise R, Wright SM. Medicine (Baltimore) 2004;83:265–273. - PubMed
    1. Global methaemoglobinaemia research output (1940-2013): a bibliometric analysis. Zyoud SH, Al-Jabi SW, Sweileh WM, Al-Khalil S, Alqub M, Awang R. Springerplus. 2015;4:626. - PMC - PubMed
    1. On the noninvasive optical monitoring and differentiation of methemoglobinemia and sulfhemoglobinemia. Baranoski GV, Chen TF, Kimmel BW, Miranda E, Yim D. J Biomed Opt. 2012;17:97005. - PubMed

Publication types

LinkOut - more resources